Literature DB >> 18077362

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.

J Kirk Harris1, Mary Ann De Groote, Scott D Sagel, Edith T Zemanick, Robert Kapsner, Churee Penvari, Heidi Kaess, Robin R Deterding, Frank J Accurso, Norman R Pace.   

Abstract

Culture of bronchoalveolar lavage fluid (BALF) is the gold standard for detection of pathogens in the lower airways in cystic fibrosis (CF). However, current culture results do not explain all clinical observations in CF, including negative culture results during pulmonary exacerbation and inflammation in the absence of pathogens. We hypothesize that organisms not routinely identified by culture occur in the CF airway and may contribute to disease. To test this hypothesis we used a culture-independent molecular approach, based on use of rRNA sequence analysis, to assess the bacterial composition of BALF from children with CF and disease controls (DC). Specimens from 42 subjects (28 CF) were examined, and approximately 6,600 total clones were screened to identify 121 species of bacteria. In general, a single rRNA type dominated clone libraries from CF specimens, but not DC. Thirteen CF subjects contained bacteria that are not routinely assessed by culture. In four CF subjects, candidate pathogens were identified and include the anaerobe Prevotella denticola, a Lysobacter sp., and members of the Rickettsiales. The presumptive pathogens Tropheryma whipplei and Granulicatella elegans were identified in cases from the DC group. The presence of unexpected bacteria in CF may explain inflammation without documented pathogens and consequent failure to respond to standard treatment. These results show that molecular techniques provide a broader perspective on airway bacteria than do routine clinical cultures and thus can identify targets for further clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077362      PMCID: PMC2154465          DOI: 10.1073/pnas.0709804104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Coordinated clearance of periciliary liquid and mucus from airway surfaces.

Authors:  H Matsui; S H Randell; S W Peretti; C W Davis; R C Boucher
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 2.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

3.  Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.

Authors:  A van Belkum; N H Renders; S Smith; S E Overbeek; H A Verbrugh
Journal:  FEMS Immunol Med Microbiol       Date:  2000-01

4.  Lower airway inflammation in infants and young children with cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; J B Carlin; R Carzino; J P Gutièrrez; J Hull; A Olinsky; E M Phelan; C F Robertson; P D Phelan
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

Review 5.  Cystic fibrosis.

Authors:  Amanda L Brennan; Duncan M Geddes
Journal:  Curr Opin Infect Dis       Date:  2002-04       Impact factor: 4.915

6.  Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

Authors:  C H Goss; N Mayer-Hamblett; M L Aitken; G D Rubenfeld; B W Ramsey
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

7.  Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Authors:  M R Shreve; S Butler; H J Kaplowitz; H R Rabin; D Stokes; M Light; W E Regelmann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Alcaligenes infection in cystic fibrosis.

Authors:  Kenneth Tan; Steven P Conway; Keith G Brownlee; Christine Etherington; Daniel G Peckham
Journal:  Pediatr Pulmonol       Date:  2002-08

9.  Microbial diversity in a hydrocarbon- and chlorinated-solvent-contaminated aquifer undergoing intrinsic bioremediation.

Authors:  M A Dojka; P Hugenholtz; S K Haack; N R Pace
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

10.  Microbiology of sputum from patients at cystic fibrosis centers in the United States.

Authors:  J L Burns; J Emerson; J R Stapp; D L Yim; J Krzewinski; L Louden; B W Ramsey; C R Clausen
Journal:  Clin Infect Dis       Date:  1998-07       Impact factor: 9.079

View more
  170 in total

Review 1.  The human microbiome and its potential importance to pediatrics.

Authors:  Coreen L Johnson; James Versalovic
Journal:  Pediatrics       Date:  2012-04-02       Impact factor: 7.124

2.  Comparison of normalization methods for construction of large, multiplex amplicon pools for next-generation sequencing.

Authors:  J Kirk Harris; Jason W Sahl; Todd A Castoe; Brandie D Wagner; David D Pollock; John R Spear
Journal:  Appl Environ Microbiol       Date:  2010-04-23       Impact factor: 4.792

Review 3.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

4.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Authors:  Edith T Zemanick; Brandie D Wagner; J Kirk Harris; Jeffery S Wagener; Frank J Accurso; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2010-06

Review 5.  Microbiome of the paranasal sinuses: Update and literature review.

Authors:  Jivianne T Lee; Daniel N Frank; Vijay Ramakrishnan
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

6.  Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.

Authors:  William G Flight; Ann Smith; Christopher Paisey; Julian R Marchesi; Matthew J Bull; Phillip J Norville; Ken J Mutton; A Kevin Webb; Rowland J Bright-Thomas; Andrew M Jones; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

7.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

8.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 9.  The cystic fibrosis airway microbiome.

Authors:  Susan V Lynch; Kenneth D Bruce
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Authors:  Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.